Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment
Keymed Biosciences Inc. (HKG: 2162), a biopharmaceutical company based in China, has announced that the...
Keymed Biosciences Inc. (HKG: 2162), a biopharmaceutical company based in China, has announced that the...
South Korea’s Ministry of Food and Drug Safety (MFDS) has unveiled an ambitious plan to...
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant...
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined...
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...
The Ministry of Human Resources and Social Security has announced key leadership changes within the...
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market,...
Yestar Healthcare Holdings Co., Ltd., a leading distributor and service provider for in vitro diagnostic...
Sanofi (EPA: SAN; NASDAQ: SNY), a leading French pharmaceutical company, has announced positive results from...
Medical device manufacturers relying on laboratory services for testing and validation data have come under...
Oxford Nanopore Technologies plc (LON: ONT), a UK-based leader in nanopore sequencing technology, has disclosed...
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has announced a...
Signet Therapeutics, a pioneering biopharmaceutical company in China specializing in cancer targeted therapies based on...
The State Council has issued the “Several Opinions on Strengthening Supervision, Preventing Risks, and Promoting...
Suzhou GenAssist Therapeutic Co., Ltd, a biopharmaceutical company based in China, has announced the commencement...
Siemens Healthineers AG has secured marketing approval from China’s National Medical Products Administration (NMPA) for...
Innovent Biologics, Inc. (HKG: 1801), a biopharmaceutical company based in China, has presented significant findings...
CSA Medical Inc., a U.S.-based medical technology company, has successfully closed a Series D financing...